Joseph D. McCracken - Concepedia

Concepedia

Author

Joseph D. McCracken

Brooke Army Medical Center

Also Known As

J D McCracken, J McCracken, J. Dean McCracken, J.D. McCracken, J.Dean McCracken, JOSEPH D. MCCRACKEN, John D. McCracken, Joseph D McCracken, Joseph D. McCracken, Joseph D. Mccracken

40

Publications

1.8K

Citations

20

H-Index

53

Concepts

All Affiliations

Brooke Army Medical Center Joint Base San Antonio Wilford Hall Ambulatory Surgical Center SWOG Cancer Research Network University of Kansas Medical Center

JD

About

Joseph D. McCracken is an author at Brooke Army Medical Center specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	15	1K
2	Health Sciences	4	4	319
3	Gastroenterology	4	4	245
4	Immunology	2	2	117
5	Hepatology	1	1	20

Joseph D. McCracken

×

25

Publications

1.8K

Citations

20

H-Index

	Year	Citations
Preoperative chemotherapy in advanced resectable head and neck cancer: Final report of the southwest oncology group David E. Schuller, David W. Stem, Barbara Metch, The Laryngoscope	1988	268
Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study. Joseph D. McCracken, Lalitha M. Janaki, John J. Crowley, Journal of Clinical Oncology Surgical OncologySouthwest Oncology GroupMetronomic ChemotherapyGliomaCancer Chemotherapy	1990	198
E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse. W J Wechter, D D Leipold, E D Murray, PubMed Tumor BiologyProstate Cancer ModelUrologyDrug TargetingChemoprevention Strategy	2000	164
Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study. Muhyi Al‐Sarraf, William S. Fletcher, N Oishi, PubMed Surgical OncologyPharmacotherapyMalignant MelanomaMetronomic ChemotherapyDermatology	1982	134
The influence of radiation therapy quality control on survival, response and sites of relapse in oat cell carcinoma of the lung. Preliminary report of a Southwest Oncology group study Joel White, Timothy Chen, Joseph D. McCracken, Cancer	1982	106
R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer. W J Wechter, Darko Kantoci, E D Murray, PubMed Chemoprevention StrategyGastrointestinal PharmacologyImmunologyGastroenterologyPharmacotherapy	1997	98
5-Fluorouracil and folinic acid in the treatment of metastatic colorectal cancer: a randomized comparison. A Southwest Oncology Group Study. G. T. Budd, Thomas R. Fleming, Ronald M. Bukowski, Journal of Clinical Oncology Gastrointestinal OncologyInfusion ArmMedicinePharmacologyFolinic Acid	1987	82
Isolated Pleural Effusion in Small Cell Lung Carcinoma: Favorable Prognosis Robert B. Livingston, Joseph D. McCracken, Christopher J. Trauth, CHEST Journal Isolated Pleural EffusionEar MoldingPathologyPleural EffusionPleural Disease	1982	81
Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes. A southwest oncology group study Harold Glucksberg, Saul E. Rivkin, Shelley L. Rasmussen, Cancer	1982	79
Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study. Frank J. Panettiere, Phyllis J. Goodman, J J Costanzi, Journal of Clinical Oncology Surgical OncologyCancer ManagementSouthwest Oncology GroupGastroenterologyPathology	1988	74

Page 1